247 related articles for article (PubMed ID: 1361079)
1. Taxol: the first of the taxanes, an important new class of antitumor agents.
Rowinsky EK; Onetto N; Canetta RM; Arbuck SG
Semin Oncol; 1992 Dec; 19(6):646-62. PubMed ID: 1361079
[TBL] [Abstract][Full Text] [Related]
2. ["Taxanes: an action mechanism at the cellular level, significant clinical progress in the treatment of cancers of the ovary and breast"].
Piccart MJ
Bull Mem Acad R Med Belg; 1998; 153(5-6):285-92; discussion 292-4. PubMed ID: 9988934
[TBL] [Abstract][Full Text] [Related]
3. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents.
Rowinsky EK
Annu Rev Med; 1997; 48():353-74. PubMed ID: 9046968
[TBL] [Abstract][Full Text] [Related]
4. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).
Pazdur R; Kudelka AP; Kavanagh JJ; Cohen PR; Raber MN
Cancer Treat Rev; 1993 Oct; 19(4):351-86. PubMed ID: 8106152
[TBL] [Abstract][Full Text] [Related]
5. [Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy].
Fumoleau P; Perrocheau G; Maugard-Louboutin C; Lemevel B
Bull Cancer; 1995 Aug; 82(8):629-36. PubMed ID: 7492819
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel and docetaxel in breast and ovarian cancer.
Drug Ther Bull; 1997 Jun; 35(6):43-6. PubMed ID: 9282422
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
Verweij J; Clavel M; Chevalier B
Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
9. Taxanes: a new class of antitumor agents.
Huizing MT; Misser VH; Pieters RC; ten Bokkel Huinink WW; Veenhof CH; Vermorken JB; Pinedo HM; Beijnen JH
Cancer Invest; 1995; 13(4):381-404. PubMed ID: 7627725
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
Hájek R; Vorlicek J; Slavik M
Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
[TBL] [Abstract][Full Text] [Related]
11. Clinical overview of the taxanes.
Goldspiel BR
Pharmacotherapy; 1997; 17(5 Pt 2):110S-125S. PubMed ID: 9322878
[TBL] [Abstract][Full Text] [Related]
12. Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice.
Sharma A; Straubinger RM; Ojima I; Bernacki RJ
J Pharm Sci; 1995 Dec; 84(12):1400-4. PubMed ID: 8748320
[TBL] [Abstract][Full Text] [Related]
13. Taxanes in adjuvant and neoadjuvant therapies for breast cancer.
O'Leary J; Volm M; Wasserheit C; Muggia F
Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):23-7. PubMed ID: 9516599
[TBL] [Abstract][Full Text] [Related]
14. Taxol: a novel investigational antimicrotubule agent.
Rowinsky EK; Cazenave LA; Donehower RC
J Natl Cancer Inst; 1990 Aug; 82(15):1247-59. PubMed ID: 1973737
[TBL] [Abstract][Full Text] [Related]
15. Taxol (paclitaxel): future directions.
Arbuck SG
Ann Oncol; 1994; 5 Suppl 6():S59-62. PubMed ID: 7865437
[TBL] [Abstract][Full Text] [Related]
16. Taxoids: effective agents in anthracycline-resistant breast cancer.
Ravdin PM
Semin Oncol; 1995 Dec; 22(6 Suppl 13):29-34. PubMed ID: 8604450
[TBL] [Abstract][Full Text] [Related]
17. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
Sparano JA
Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
[TBL] [Abstract][Full Text] [Related]
18. [Taxanes in the treatment of breast and ovarian cancers: current indications and results].
Espié M; Cuvier C; Gorins A; Marty M
Contracept Fertil Sex; 1998 Nov; 26(11):805-11. PubMed ID: 9864888
[TBL] [Abstract][Full Text] [Related]
19. Taxol in ovarian cancer.
Runowicz CD; Wiernik PH; Einzig AI; Goldberg GL; Horwitz SB
Cancer; 1993 Feb; 71(4 Suppl):1591-6. PubMed ID: 8094322
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel.
Cortes JE; Pazdur R
J Clin Oncol; 1995 Oct; 13(10):2643-55. PubMed ID: 7595719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
